However, investors should note that the net income was boosted by a one-time $31.6 million gain from biological assets. Two years ago, Aurora Cannabis disclosed plans to focus on the higher-margin ...
Aurora's business is showing some signs of progress, and it has come a long way over the years in becoming less dependent on the Canadian consumer cannabis market. However, whether investors ...
Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw unusually large options trading on Wednesday.Investors acquired 14,034 call options on the stock. This is an increase of 480% compared to ...
Aurora Cannabis has transformed its margins ... the back of woeful financial results across the sector and a lack of investor interest. As U.S. legalization continues to get kicked down the ...
Aurora Cannabis Inc. closed 54.01% short of its 52-week high of $9.35, which the company achieved on April 30th.
However, investors should note that the net income was boosted by a one-time $31.6 million gain from biological assets. Two years ago, Aurora Cannabis disclosed plans to focus on the higher-margin ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 10, 2025. Let’s take ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results